Changes in regional brain activity in major depression after successful treatment with antidepressant drugs

被引:45
|
作者
Ogura, A
Morinobu, S
Kawakatsu, S
Totsuka, S
Komatani, A
机构
[1] Yamagata Univ, Sch Med, Dept Neuropsychiat, Yamagata 99023, Japan
[2] Yamagata Univ, Sch Med, Dept Radiol, Yamagata 99023, Japan
关键词
major depression; SPECT; cerebral blood flow;
D O I
10.1111/j.1600-0447.1998.tb10042.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Relative regional cerebral blood flow was measured with single photon emission computed tomography (SPECT) using Tc-99m-hexamethyl-propyleneamine oxime (Tc-99m-HMPAO) in 16 patients with major depression while they were in the depressed slate as well as in remission. All patients were closely matched with regard to medication status. In the depressed state. significant reductions in tracer uptake were found in the left superior frontal, bilateral parietal and right lateral temporal cortex. During remission. significant increases in uptake were found in the left superior frontal, right parietal and right lateral temporal cortex. There were no significant differences in tracer uptake between patients in remission and controls. These findings suggest that the regional decreases in tracer uptake observed in the depressed state might be a stale-related abnormality.
引用
收藏
页码:54 / 59
页数:6
相关论文
共 50 条
  • [41] Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: A prospective study
    Oquendo, MA
    Kamali, M
    Ellis, SP
    Grunebaum, MF
    Malone, KM
    Brodsky, BS
    Sackeim, HA
    Mann, JJ
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (10): : 1746 - 1751
  • [42] Changes in neural circuitry of language before and after treatment of major depression
    Abdullaev, Y
    Kennedy, BL
    Tasman, A
    [J]. HUMAN BRAIN MAPPING, 2002, 17 (03) : 156 - 167
  • [43] BDNF and pro-BDNF in serum and exosomes in major depression: Evolution after antidepressant treatment
    Gelle, Thibaut
    Samey, Rayhanatou Altine
    Plansont, Brigitte
    Bessette, Barbara
    Jauberteau-Marchan, Marie-Odile
    Lalloue, Fabrice
    Girard, Murielle
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 109
  • [44] TREATMENT OF MAJOR DEPRESSION WITH STEROID SUPPRESSIVE DRUGS
    MURPHY, BEP
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 39 (02): : 239 - 244
  • [45] New antidepressant drugs and the treatment of depression in the medically ill patient
    Stoudemire, A
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 1996, 19 (03) : 495 - &
  • [46] Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response
    Robert Keers
    Rudolf Uher
    [J]. Current Psychiatry Reports, 2012, 14 : 129 - 137
  • [47] Black and White Patients Response to Antidepressant Treatment for Major Depression
    Roy V. Varner
    Pedro Ruiz
    David R. Small
    [J]. Psychiatric Quarterly, 1998, 69 : 117 - 125
  • [48] Race, Genetic Ancestry and Response to Antidepressant Treatment for Major Depression
    Eleanor Murphy
    Liping Hou
    Brion S Maher
    Girma Woldehawariat
    Layla Kassem
    Nirmala Akula
    Gonzalo Laje
    Francis J McMahon
    [J]. Neuropsychopharmacology, 2013, 38 : 2598 - 2606
  • [49] Tryptophan and tyrosine availability and response to antidepressant treatment in major depression
    Porter, RJ
    Mulder, RT
    Joyce, PR
    Luty, SE
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2005, 86 (2-3) : 129 - 134
  • [50] IGF-I in major depression and antidepressant treatment response
    Kopczak, Anna
    Stalla, Guenter Karl
    Uhr, Manfred
    Lucae, Susanne
    Hennings, Johannes
    Ising, Marcus
    Holsboer, Florian
    Kloiber, Stefan
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (06) : 864 - 872